Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Neogen Chemicals Ltd

NEOGEN
NSE
1,655.90
0.35%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Neogen Chemicals Ltd

NEOGEN
NSE
1,655.90
0.35%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
4,534Cr
Close
Close Price
1,655.90
Industry
Industry
Speciality Chemicals
PE
Price To Earnings
221.38
PS
Price To Sales
5.54
Revenue
Revenue
818Cr
Rev Gr TTM
Revenue Growth TTM
5.66%
PAT Gr TTM
PAT Growth TTM
-60.04%
Peer Comparison
How does NEOGEN stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
NEOGEN
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
204165162164200180193201203187209220
Growth YoY
Revenue Growth YoY%
30.111.59.2-11.7-2.19.119.622.51.63.87.99.2
Expenses
ExpensesCr
171137136144164149159167166155179188
Operating Profit
Operating ProfitCr
332826203631353536323032
OPM
OPM%
16.017.016.012.317.917.117.917.217.916.914.414.5
Other Income
Other IncomeCr
22222211-13122
Interest Expense
Interest ExpenseCr
91111111010131313131922
Depreciation
DepreciationCr
456667777677
PBT
PBTCr
21141162216151541456
Tax
TaxCr
643564551422
PAT
PATCr
1410811711111021034
Growth YoY
PAT Growth YoY%
-8.5-12.2-19.8-92.818.317.638.4844.3-85.8-10.6-69.3-63.1
NPM
NPM%
7.05.94.90.68.56.45.75.01.25.51.61.7
EPS
EPS
5.73.93.20.46.44.34.23.80.93.91.31.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
16123930600686691778818
Growth
Revenue Growth%
48.328.1-100.00.712.65.2
Expenses
ExpensesCr
13219624800575581641688
Operating Profit
Operating ProfitCr
29435800112110136130
OPM
OPM%
18.018.219.016.315.917.515.9
Other Income
Other IncomeCr
1100058-10-8
Interest Expense
Interest ExpenseCr
1012120029424966
Depreciation
DepreciationCr
2350016232827
PBT
PBTCr
1729410071535029
Tax
TaxCr
6812002117159
PAT
PATCr
1121290050363520
Growth
PAT Growth%
90.736.8-100.0-28.7-2.3-43.4
NPM
NPM%
6.88.89.47.35.24.52.4
EPS
EPS
5.510.412.313.418.720.014.013.27.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
2020230025262626
Reserves
ReservesCr
305013300458734763773
Current Liabilities
Current LiabilitiesCr
8411715000410527733837
Non Current Liabilities
Non Current LiabilitiesCr
46604900162174225665
Total Liabilities
Total LiabilitiesCr
180246355001,0541,4611,7472,302
Current Assets
Current AssetsCr
107160231006567841,0001,319
Non Current Assets
Non Current AssetsCr
748712400398678747983
Total Assets
Total AssetsCr
180246355001,0541,4611,7472,302

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
12-4-35841-30-29196
Investing Cash Flow
Investing Cash FlowCr
-13-20-29-135-146-94-216-317
Financing Cash Flow
Financing Cash FlowCr
0246351188100237113
Net Cash Flow
Net Cash FlowCr
-10-1044-25-8-8
Free Cash Flow
Free Cash FlowCr
-2-22-6161-169-133-332-121
CFO To PAT
CFO To PAT%
107.9-17.6-120.6-60.7-81.8562.7
CFO To EBITDA
CFO To EBITDA%
40.9-8.5-59.5-27.2-26.5143.8

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
008192,0174,3523,2003,1474,076
Price To Earnings
Price To Earnings
0.00.028.664.497.564.088.3117.0
Price To Sales
Price To Sales
0.00.02.76.08.94.74.65.2
Price To Book
Price To Book
0.00.05.211.09.96.64.15.2
EV To EBITDA
EV To EBITDA
2.72.616.431.832.234.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
41.141.139.943.444.645.6
OPM
OPM%
18.018.219.016.315.917.5
NPM
NPM%
6.88.89.47.35.24.5
ROCE
ROCE%
21.422.118.411.78.17.1
ROE
ROE%
21.829.818.310.44.74.4
ROA
ROA%
6.18.58.14.72.42.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Neogen Chemicals Limited, founded in 1989 and headquartered in India, is a leading manufacturer of bromine- and lithium-based specialty chemicals. With over 35 years of experience, the company has evolved from a niche player to a globally recognized supplier serving high-value industries such as pharmaceuticals, agrochemicals, electronics, polymers, construction, and increasingly, energy storage and electric vehicles (EVs). As of November 2025, Neogen is actively transforming into a **technology-driven, agile specialty chemicals leader**, with a strategic focus on the **lithium-ion battery materials value chain**. --- ### **Core Business Segments** Neogen operates across four main chemical domains: 1. **Bromine Compounds**: Organic derivatives containing bromine, chlorine, fluorine, iodine, and Grignard reagents used in pharmaceuticals, agrochemicals, and electronic chemicals. 2. **Organolithium/ Organometallic Products**: Key reagents such as *n-Butyl Lithium (BuLi)* for lithiation reactions in complex synthesis; critical in pharma, agrochemicals, and semiconductor manufacturing. 3. **Advanced Intermediates**: Multi-step bromination-based chemical solutions that deliver forward-integrated, high-value products used in APIs, agrochemicals, and specialty polymers. 4. **Custom Synthesis & Contract Manufacturing (CSM)**: Tailored chemical solutions developed in-house for global clients across pharma, agrochemicals, flavors, fragrances, and electronics sectors. Its inorganic chemicals portfolio includes **specialty lithium-based products** with applications in eco-friendly VAM (Vapor Absorption Chillers), construction, and increasingly, battery technologies. --- ### **Strategic Growth: Entry into Battery Materials** Neogen has positioned itself as a first-mover in India’s emerging lithium-ion battery ecosystem, driven by rising EV adoption, government incentives (e.g., PLI Scheme), and global demand for non-Chinese supply chains. #### **Neogen Ionics Limited (NIL) – Wholly-Owned Subsidiary** Established in 2023, **Neogen Ionics Limited** is the dedicated arm for battery materials. It focuses on: - Solid LiPF₆ (lithium hexafluorophosphate) salt - Electrolyte formulation - Additives and services for advanced chemistry cell (ACC) batteries NIL is developing **India's largest integrated battery materials plant** at **Pakhajan, Dahej PCPIR (Gujarat)**, with full backward integration from lithium carbonate to finished electrolytes. #### **Key Projects & Capacity Expansion (FY25–FY27)** | Facility | Location | Planned Capacity | Technology Source | |--------|--------|------------------|-------------------| | Greenfield Electrolyte Plant | Pakhajan, Dahej PCPIR | 30,000 MT/year | Licensed from MUIS (Japan) | | Greenfield Lithium Electrolyte Salt Plant | Pakhajan, Dahej PCPIR | 3,000 MT/year | Proprietary in-house tech | | Dahej SEZ Expansion | Dahej, Gujarat | +400 MT salt; +2,000 MT electrolyte | Indigenous + MUIS | | **Total Combined Capacity** | Across Dahej sites | **32,000 MT electrolyte**, **5,500 MT lithium salts/additives** | - | | **CAPEX Investment** | | ₹1,500 Crore | Debt-financed; project finance secured | - **Commercial Timelines (Nov 2025 Status):** - Electrolyte production expected by **1H FY27** (April–September 2026) - Lithium salt production delayed to **2H FY27** due to technology homologation with Japanese partners - Mechanical completion of Pakhajan greenfield plant expected by **end of 2025** - **Peak Revenue Potential:** INR **2,500–2,950 crore by FY29**, contingent on lithium prices and global off-take. --- ### **Strategic Partnerships** Neogen has formed key alliances to accelerate its transition into the battery sector: - **MU Ionic Solutions Corporation (MUIS, Japan):** Secured an **exclusive technology license** to manufacture high-quality lithium-ion battery electrolytes — the **first ever granted globally by MUIS**. This gives Neogen a first-mover advantage and alignment with global quality and safety standards. - **Morita Chemical Industries (Japan):** Entered into a **landmark Indo-Japan joint venture** through **Neogen Morita New Materials Limited (NML)**, aiming to scale up LiPF₆ electrolyte salt production. Morita brings 30+ years of experience in large-scale salt manufacturing, enhancing production know-how, process safety, and international customer approvals. This J-V makes Neogen the **first Indo-Japan JV in the battery materials space**, signaling strong global interest in the India+1 supply chain initiative. --- ### **Technology & R&D Capabilities** - **R&D Units:** Two dedicated centers in **Mahape (Navi Mumbai)** and **Vadodara**, established since 2001. - **Team:** 116-member R&D team including **11 PhD scientists**; ~13% of workforce dedicated to R&D. - **Leadership Involvement:** Managing Director **Dr. Harin Kanani** (PhD, University of Maryland) directly oversees R&D. - **Portfolio Growth:** Expanded from **20 products in 2001** to **258 products by Q2 FY26**. - **Focus Areas:** Complex chemistries including lithiation, Grignard reactions, Suzuki coupling, biocatalysis, flow chemistry, and high-vacuum distillation. - **Innovation:** Strong emphasis on **in-house process know-how**, custom molecule development, and **lithium recycling from by-products**. --- ### **Manufacturing Infrastructure** - **Six Manufacturing Sites:** Mahape (Navi Mumbai), Karakhadi & Vadodara (Gujarat), Dahej SEZ (Gujarat), Patancheru (Hyderabad), and a new **65-acre greenfield site at Pakhajan, Dahej PCPIR**. - **Reactor Capacity (FY24–25):** - Organic chemicals: **438 m³** - Inorganic chemicals: **39 metric tons** - **Patancheru Facility Expansion:** After acquisition of BuLi Chem, de-bottlenecking increased organolithium capacity from **120 to 300 MTPA**. - **Certifications:** ISO 9001, ISO 14001, ISO 45001, and compliance with US FDA cGMP standards. --- ### **Growth Enablers & Competitive Advantages** 1. **First-Mover Advantage in Battery Materials:** - One of only **2–3 non-Chinese LiPF₆ salt producers globally**. - Exclusive access to **MUIS technology**, offering quality assurance and faster customer approvals. - India’s **first company to be PPAP-certified** by a leading giga-scale Indian battery manufacturer — marking a major milestone in supply chain integration. 2. **Vertical Integration & Supply Chain Security:** - **Backward integration** into organolithium and electrolyte salt production. - **Lithium recycling** capabilities reduce raw material costs and environmental footprint. - Long-term supply agreements with **top 2–3 global lithium miners**; dominant importer of **lithium carbonate & hydroxide** in India. 3. **China+1 Strategy Beneficiary:** - Strong global interest from **OEMs and cell makers** seeking **IRA-compliant, non-FEOC (Foreign Entity of Concern)** supply chains. - Positioning as a **low-cost, reliable alternative outside China**. 4. **Custom Synthesis Momentum:** - Over 258 products offered; strong traction in pharma and electronics. - Export contracts with **EU, U.S., Japan, Korea, Middle East**. - Growing CSM revenue stream with long-term supply agreements. 5. **Government Support:** - Benefiting from **PLI Scheme for ACC batteries**, **zero customs duty on lithium**, and "Make in India" initiatives. --- ### **Recent Key Milestones (Nov 2025 Update)** - Received **PPAP certification** from a major Indian giga-scale battery manufacturer — a rare achievement in India. - Secured **provisional approval** from a **major international customer** for lithium electrolyte salt (final approval expected Q4 FY26). - **Sample batches approved** by several global clients; commercial supply ongoing for early customers. - Dahej SEZ facility already producing **trial and early commercial volumes** of electrolytes and salts. - **Strategic land acquisition** of **270,740 m² across Dahej and Pakhajan** for future expansion.